Fabius, well I think the results that were submitted to adcomm show the IV resistance worked. The other test results the company did share showed Rexista was the only drug that was going to be able to taken with or without food which makes it better than the others. Slong as the phase 2 and 3 studies show the same results for oral and Nasal, I feel the drug will be approved. I really do believe in the technology which is why I stayed invested. likewise they do have 4 approved drugs which shows their other technology works.
So, if the technology is working but the management has been the detractor. That now will go away with the next dilution. he will need to dilute a minimum of 25% just to get another 3 to 4 million to keep the doors open. at which point, USB has 16% I believe, Armistice has 19%. Either one could potentially buy the next offering which honestly would be in their best interest.
So by changing the management, someone could force Odidi to take these offers he is no doubt turning away feeling they are inferior. honestly, if the big boys double down why wouldn't or shouldn't we? It is probably our only chance to negate the dilution we have suffered up to this point.
lets face it, while he has been a problem not getting deals done, the share price has still also been manipulated down. its the combination of the two which killed us. Which means IPCI is actually undervalued. even competitors which have no pipeline and no approvals are selling at a higher market cap.
so yes at least for me, its reason to take advantage at these levels. everyone has said for sometime he needs to get back into the lab and let someone else run things. well, that time is fast approaching. so what would be the problem is people get what they wanted?
the only other option is he inks a deal to stave off another dilution to maintain control. at which point, while he would still remain a deal at this point we still win!
